Company: VCYT
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001384101-25-000060
Chunk: 34

Company: VERACYTE, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
1)3,385 2,846 Allocation of facilities and IT expenses3,372 2,943 Total cost of testing revenue28,260 25,979 Cost of product revenue:Product costs109 1,263 License fees and royalties324 436 Other cost of product revenue (2)792 824 Allocation of facilities and IT expenses197 121 Total cost of product revenue1,422 2,644 Cost of biopharmaceutical and other revenue:Compensation expense1,240 1,462 Other cost of biopharmaceutical and other revenue (3)1,044 949 Allocation of facilities and IT expenses414 427 Total cost of biopharmaceutical and other revenue2,698 2,838 Intangible asset amortization - cost of revenue2,585 2,915 Gross profit79,508 62,468 Operating expenses:Research and development:Compensation expense9,748 9,085 Direct research and development expense4,141 3,874 Other research and development expenses (4)1,815 1,519 Allocation of facilities and IT expenses2,016 1,487 Total research and development17,720 15,965 Selling and marketing:Compensation expense17,635 17,622 Direct marketing expense710 1,138 Other selling and marketing expenses (5)3,853 3,414 Allocation of facilities and IT expenses2,256 1,608 Total selling and marketing24,454 23,782 General and administrative:Compensation expense20,173 17,759 Other general and administrative expenses (6)21,890 15,037 Allocation of facilities and IT expenses(8,255)(6,586)Total general and administrative33,808 26,210 Intangible asset amortization - operating expenses622 738 Other income, net(4,524)(2,748)Income tax provision (benefit)381 (44)Net income (loss)$7,047 $(1,864)________________

17

(1)Other cost of testing revenue includes cytopathology services, depreciation and amortization and other expenses.(2)Other cost of product revenue includes license fees and royalties, depreciation and amortization and other expenses.(3)Other cost of biopharmaceutical and other revenue includes license fees and royalties, depreciation and amortization and other expenses.(